Product image of Glukóza Braun (Glucose Monohydrate) supplied by GNH India

Glukóza Braun

Active Ingredient:
Glucose Monohydrate
Origin:
EU

Glukóza Braun (Glucose Monohydrate)

Glukóza Braun is a sterile intravenous solution containing glucose monohydrate as the active ingredient. It is supplied as a solution for injection, intended for parenteral administration. The product is manufactured in the European Union and is classified as an excipient/solvent used to provide carbohydrate energy and raise plasma glucose levels. It is commonly employed in clinical settings for hypoglycemia, parenteral nutrition, and fluid‑electrolyte replacement therapy.

Manufacturer / TM Owner

B.Braun Melsungen Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glukóza Braun is indicated for several clinical situations where rapid carbohydrate supplementation is required.

  • Treatment of acute hypoglycemia in patients unable to take oral glucose.
  • Component of parenteral nutrition regimens to meet caloric needs.
  • Fluid and electrolyte replacement in perioperative or trauma care.
  • Support during diagnostic procedures that require fasting, such as PET scans.
  • Management of insulin‑induced hyperglycemia during intensive care.

Side Effects

Adverse reactions to Glukóza Braun are generally related to the intravenous administration of a carbohydrate solution.

Common

  • Mild hyperglycemia.
  • Local irritation at the injection site.
  • Nausea or vomiting.
  • Transient electrolyte shifts (e.g., low potassium).

Serious

  • Severe hyperglycemia with osmotic diuresis.
  • Allergic or anaphylactic reaction.
  • Volume overload leading to pulmonary edema.
  • Hyperosmolar hyperglycemic state.

Precautions & Warnings

When using Glukóza Braun, clinicians should consider several precautionary measures to ensure patient safety.

  • Assess blood glucose levels before and during infusion.
  • Adjust infusion rate in patients with renal or cardiac impairment.
  • Monitor electrolyte concentrations, especially potassium and sodium.
  • Use caution in patients with known hypersensitivity to glucose solutions.
  • Avoid rapid large-volume administration in neonates and infants.
  • Ensure aseptic technique to prevent contamination.

Avoid Interactions

Glukóza Braun may interact with other medications or clinical conditions, influencing its safety or efficacy.

Avoid

  • Co‑administration with high‑dose insulin without glucose monitoring.
  • Concurrent use of hypertonic saline solutions that may exacerbate hyperosmolarity.

Use with caution

  • Loop diuretics, which can affect fluid balance.
  • Beta‑blockers, which may mask hypoglycemia symptoms.
  • Corticosteroids, which can increase blood glucose levels.
  • Sodium‑containing medications that may contribute to volume overload.

Frequently Asked Questions

The active ingredient is glucose monohydrate, a simple carbohydrate used to raise plasma glucose levels when given intravenously.

It is commonly used for acute hypoglycemia, as part of parenteral nutrition, and for fluid and electrolyte replacement during surgery or trauma care.

Glukóza Braun is supplied as a sterile solution for injection and is administered intravenously under aseptic conditions.

Use in neonates and infants should be cautious, with attention to infusion rate and volume to avoid rapid fluid shifts.

Blood glucose, electrolyte levels, and fluid balance should be regularly monitored, especially in patients with renal or cardiac disease.

Compatibility should be assessed; avoid mixing with hypertonic saline or other high‑osmolarity solutions without proper dilution.

Common side effects include mild hyperglycemia, local irritation at the injection site, nausea, and transient electrolyte changes.

Serious reactions can include severe hyperglycemia, allergic or anaphylactic responses, volume overload leading to pulmonary edema, and hyperosmolar hyperglycemic state.

When used with insulin, glucose levels must be closely monitored to avoid excessive hypoglycemia or hyperglycemia.

The solution should be stored according to the manufacturer’s instructions, typically at controlled room temperature and protected from light.

Patients with diabetes may receive Glukóza Braun, but dosing and monitoring must be individualized to prevent hyperglycemia.

Glukóza Braun is classified as an excipient/solvent and is not listed as a controlled substance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glucose Monohydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT